Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Hea (Q38004123)
Jump to navigation
Jump to search
scientific article published on 18 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Hea |
scientific article published on 18 April 2012 |
Statements
Niacin and statin combination therapy for atherosclerosis regression and prevention of cardiovascular disease events: reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial with previous surrogate endpoint trials (English)
Roger S Blumenthal
Michael J Blaha
Christopher T Sibley
Jefferson T Baer